INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2024, Number 1

Cardiovasc Metab Sci 2024; 35 (1)

An unexpected germ: atypical presentation of Vagococcus fluvialis pocket infection in a cardiac pacing device

Marín-Velásquez, Jorge Eduardo; Velásquez, Juanita; Sotelo-Narváez, Jorge Enrique; Aristizábal-Aristizábal, Julián Miguel; Díaz-Martínez, Juan Carlos; Duque-Ramírez, Mauricio

ABSTRACT

Advances in cardiac implantable electronic devices (CIED) technology have enabled them to play a relevant role in heart disease. Although complications have decreased, CIED-related infection persists as one of the problems that has the greatest impact on the patient and the health system. Infections due to unusual germs generate additional morbidity and increased costs of care but can have a favorable course with early diagnosis and treatment. The case of a patient with clinical signs and symptoms of CIED pocket infection by Vagococcus fluvialis, without systemic infection or endocarditis, is presented for the first time in the literature. Timely treatment allowed a favorable evolution. New diagnostic and therapeutic challenges come from the hand of more complex patients.
  FULL TEXT PDF   FLIPBOOK

Keywords

cardiac implantable electronic devices complications pocket infection endocarditis Vagococcus fluvialis




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • Perception among family members and physicians about the recommendation for...
    2025, Vol.36, Núm. 2
  • Diagnostic challenge: cardiac myeloid sarcoma in a patient with acute myeloid...
    2025, Vol.36, Núm. 2
  • Atherogenic risk profiles and cardiovascular risk assessment in hospitalized...
    2025, Vol.36, Núm. 2
  • Metabolic-Adipose-Cardio-Arterial-Renal-Enterohepatic-Neurological connection...
    2025, Vol.36, Núm. 2
  • Gym benefits?
    2025, Vol.36, Núm. 2
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3


Cardiovascular and Metabolic Science Vol. 35, Num. 1, Enero-Marzo 2024. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 http://www.medigraphic.com/cms ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-022717130200-102. ISSN impreso: 2683-2828, ISSN electrónico: 2954-3835. Otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 14 de abril de 2025.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/